New drug aims to protect hearts during major attacks
Disease control
Recruiting now
This study is testing if a new drug called RTP-026 can help reduce heart muscle damage in people who have just had a major heart attack (STEMI). About 96 participants will receive either the drug or a placebo through three IV infusions shortly after their standard artery-opening …
Phase: PHASE2 • Sponsor: ResoTher Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC